226 related articles for article (PubMed ID: 23880676)
1. Rare diseases research: expanding collaborative translational research opportunities.
Groft SC
Chest; 2013 Jul; 144(1):16-23. PubMed ID: 23880676
[TBL] [Abstract][Full Text] [Related]
2. New and evolving rare diseases research programs at the National Institutes of Health.
Groft SC; Rubinstein YR
Public Health Genomics; 2013; 16(6):259-67. PubMed ID: 24503586
[TBL] [Abstract][Full Text] [Related]
3. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data.
Groft SC; Posada de la Paz M
Adv Exp Med Biol; 2017; 1031():3-21. PubMed ID: 29214563
[TBL] [Abstract][Full Text] [Related]
4. Advocacy groups and their role in rare diseases research.
Dunkle M; Pines W; Saltonstall PL
Adv Exp Med Biol; 2010; 686():515-25. PubMed ID: 20824463
[TBL] [Abstract][Full Text] [Related]
5. New NIH center broadens scope of translational research.
Jenks S
J Natl Cancer Inst; 2012 May; 104(10):728-31. PubMed ID: 22544941
[No Abstract] [Full Text] [Related]
6. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
Chung TD
Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
[TBL] [Abstract][Full Text] [Related]
7. A past with uncertainty, a future with hope--rare disease day 2014 from a USA perspective.
Groft SC
Orphanet J Rare Dis; 2014 Feb; 9():31. PubMed ID: 24580809
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012.
O'Reilly M; Kohn DB; Bartlett J; Benson J; Brooks PJ; Byrne BJ; Camozzi C; Cornetta K; Crystal RG; Fong Y; Gargiulo L; Gopal-Srivastava R; High KA; Jacobson SG; Jambou RC; Montgomery M; Rosenthal E; Samulski RJ; Skarlatos SI; Sorrentino B; Wilson JM; Xie Y; Corrigan-Curay J
Hum Gene Ther; 2013 Apr; 24(4):355-62. PubMed ID: 23517518
[TBL] [Abstract][Full Text] [Related]
9. The value of research collaborations and consortia in rare cancers.
Blay JY; Coindre JM; Ducimetière F; Ray-Coquard I
Lancet Oncol; 2016 Feb; 17(2):e62-e69. PubMed ID: 26868355
[TBL] [Abstract][Full Text] [Related]
10. Expanding research to provide an evidence base for nutritional interventions for the management of inborn errors of metabolism.
Camp KM; Lloyd-Puryear MA; Yao L; Groft SC; Parisi MA; Mulberg A; Gopal-Srivastava R; Cederbaum S; Enns GM; Ershow AG; Frazier DM; Gohagan J; Harding C; Howell RR; Regan K; Stacpoole PW; Venditti C; Vockley J; Watson M; Coates PM
Mol Genet Metab; 2013 Aug; 109(4):319-28. PubMed ID: 23806236
[TBL] [Abstract][Full Text] [Related]
11. An NIH intramural percubator as a model of academic-industry partnerships: from the beginning of life through the valley of death.
Emmert-Buck MR
J Transl Med; 2011 May; 9():54. PubMed ID: 21548992
[TBL] [Abstract][Full Text] [Related]
12. The path to personalized medicine.
Hamburg MA; Collins FS
N Engl J Med; 2010 Jul; 363(4):301-4. PubMed ID: 20551152
[No Abstract] [Full Text] [Related]
13. A call to study orphan diseases.
Alawi F
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Aug; 126(2):95-97. PubMed ID: 29861184
[No Abstract] [Full Text] [Related]
14. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
15. Clinical research for rare disease: opportunities, challenges, and solutions.
Griggs RC; Batshaw M; Dunkle M; Gopal-Srivastava R; Kaye E; Krischer J; Nguyen T; Paulus K; Merkel PA;
Mol Genet Metab; 2009 Jan; 96(1):20-6. PubMed ID: 19013090
[TBL] [Abstract][Full Text] [Related]
16. An NIH National Center for Advancing Translational Sciences: is a focus on drug discovery the best option?
Littman BH
Nat Rev Drug Discov; 2011 Jun; 10(6):471. PubMed ID: 21597471
[No Abstract] [Full Text] [Related]
17. NIH TRND program: successes in preclinical therapeutic development.
McKew JC; Pilon AM
Trends Pharmacol Sci; 2013 Feb; 34(2):87-9. PubMed ID: 23174531
[No Abstract] [Full Text] [Related]
18. Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS).
; Shamoon H; Center D; Davis P; Tuchman M; Ginsberg H; Califf R; Stephens D; Mellman T; Verbalis J; Nadler L; Shekhar A; Ford D; Rizza R; Shaker R; Brady K; Murphy B; Cronstein B; Hochman J; Greenland P; Orwoll E; Sinoway L; Greenberg H; Jackson R; Coller B; Topol E; Guay-Woodford L; Runge M; Clark R; McClain D; Selker H; Lowery C; Dubinett S; Berglund L; Cooper D; Firestein G; Johnston SC; Solway J; Heubi J; Sokol R; Nelson D; Tobacman L; Rosenthal G; Aaronson L; Barohn R; Kern P; Sullivan J; Shanley T; Blazar B; Larson R; FitzGerald G; Reis S; Pearson T; Buchanan T; McPherson D; Brasier A; Toto R; Disis M; Drezner M; Bernard G; Clore J; Evanoff B; Imperato-McGinley J; Sherwin R; Pulley J
Clin Transl Sci; 2012 Apr; 5(2):121-9. PubMed ID: 22507116
[TBL] [Abstract][Full Text] [Related]
19. Preparing for the Future of Rare Diseases.
Groft SC; Posada de la Paz M
Adv Exp Med Biol; 2017; 1031():641-648. PubMed ID: 29214596
[TBL] [Abstract][Full Text] [Related]
20. Working with the CTSA Consortium: what we bring to the table.
Steele SJ
Sci Transl Med; 2010 Dec; 2(63):63mr5. PubMed ID: 21178135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
